Abstract
Minimally invasive surgery plays an increasingly important role in the management of bone disease in patients with myeloma. The spine is the most common site of bone involvement in myeloma, and minimally invasive vertebral augmentation techniques have been developed which are safe and effective in relieving pain related to vertebral compression fractures in patients with myeloma. Vertebroplasty relieves pain and stabilizes the fractured vertebral body by injecting bone cement percutaneously into the cancellous area, however more recently its role in pain management has been questioned in two double blinded randomized clinical trials. Kyphoplasty is a similar technique, but uses an inflatable tamp to create a uniform cavity in which the bone cement is injected. Compared with vertebroplasty, kyphoplasty is associated with less cement leakage and has the added advantage of restoring vertebral height, which relieves stress on adjacent vertebral bodies and may reduce the risk of additional fractures. Continued improvements in myeloma therapy and the development of these minimally invasive techniques have increased the potential for more patients to be eligible for vertebral augmentation, which may have a favorable impact on pain, disability, quality of life, and even reduction in mortality. Vertebral augmentation is the procedure of choice for myeloma patients with severe pain related to vertebral compression fractures and may play a role in relieving pain and preventing impending fractures in patients with other conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Durie BG. New approaches to treatment for multiple myeloma: durable remission and quality of life as primary goals. Clin Lymphoma Myeloma. 2005;6:181–190.
Durie BG, Kyle RA, Belch A, et al. Myeloma management guidelines: a consensus report from the scientific advisors of the international myeloma foundation. Hematol J. 2003;4:379–398.
Kyle RA. Multiple myeloma: review of 869 cases. Mayo Clin Proc. 1975;50:29–40.
Cotten A, Dewatre F, Cortet B, et al. Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Radiology. 1996;200:525–530.
Hussein MA, Vrionis FD, Allison R, et al. The role of vertebral augmentation in multiple myeloma: international myeloma working group consensus statement. Leukemia. 2008;22:1479–1484.
Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1999;159:1215–1220.
Djulbegovic B, Wheatley K, Ross J, et al. Cochrane Database Syst Rev. 2002;2: CD003188.
Berenson JR, Hillner BE, Kyle RA, et al. American Society of Clinical Oncology bisphosphonates expert panel. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2002;20: 3719–3736.
Berenson JR, Lichtenstein A, Porter L, et al. Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group. J Clin Oncol. 1998;16:593–602.
Berenson JR, Lichtenstein A, Porter L, et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl J Med. 1996;334:488–493.
McCloskey EV, MacLennan IC, Drayson MT, Chapman C, Dunn J, Kanis JA. A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC working party of leukaemia in adults. Br J Haematol. 1998;100:317–325.
McCloskey EV, Dunn JA, Kanis JA, MacLennan IC, Drayson MT. Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma. Br J Haematol. 2001;113:1035–1043.
Gertz BJ, Holland SD, Kline WF, et al. Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther. 1995;58:288–298.
Rosen LS, Gordon D, Kaminski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J. 2001;7:377–387.
Zeifang F, Zahlten-Hinguranage A, Goldschmidt H, Cremer F, Bernd L, Sabo D. Long-term survival after surgical intervention for bone disease in multiple myeloma. Ann Oncol. 2005;16:222–227.
Chang SA, Lee SS, Ueng SW, Yuan LJ, Shih CH. Surgical treatment for pathological long bone fracture in patients with multiple myeloma: a retrospective analysis of 22 cases. Chang Gung Med J. 2001;24:300–306.
Harrington KD. Orthopedic surgical management of skeletal complications of malignancy. Cancer. 1997;80(8 Suppl):1614–1627.
Papagelopoulos PJ, Galanis EC, Greipp PR, Sim FH. Prosthetic hip replacement for pathologic or impending pathologic fractures in myeloma. Clin Orthop Relat Res. 1997;341:192–205.
Colyer RA. Surgical stabilization of pathological neoplastic fractures. Curr Probl Cancer. 1986;10:117–168.
Jacofsky DJ, Haidukewych GJ. Management of pathologic fractures of the proximal femur: state of the art. J Orthop Trauma. 2004;18:459–469.
Sapkota BH, Hirsch AE, Yoo AJ, et al. Treatment of metastatic carcinoma to the hip with CT-guided percutaneous acetabuloplasty: report of four cases. J Vasc Interv Radiol. 2009;20:548–552.
Lieberman I, Reinhardt MK. Vertebroplasty and kyphoplasty for osteolytic vertebral collapse. Clin Orthop Relat Res. 2003;415(Suppl):S176–S186.
Shepherd S. Radiotherapy and the management of metastatic bone pain. Clin Radiol. 1988;39:547–550.
Yeh HS, Berenson JR. Treatment for myeloma bone disease. Clin Cancer Res. 2006;12(20 Part 2):6279s–6284s.
Dudeney S, Lieberman IH, Reinhardt MK, Hussein M. Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma. J Clin Oncol. 2002;20:2382–2387.
Galibert P, Deramond H, Rosat P, Le Gars D. [Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty]. Neurochirurgie. 1987;33:166–168 (French).
Deramond H, Depriester C, Galibert P, Le Gars D. Percutaneous vertebroplasty with polymethylmethacrylate. Technique, indications, and results. Radiol Clin North Am. 1998;36:533–546.
Deramond H, Wright NT, Belkoff SM. Temperature elevation caused by bone cement polymerization during vertebroplasty. Bone. 1999;25(2 Suppl):17S–21S.
Jensen ME, Evans AJ, Mathis JM, Kallmes DF, Cloft HJ, Dion JE. Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects. AJNR Am J Neuroradiol. 1997;18:1897–1904.
Kayanja M, Evans K, Milks R, Lieberman IH. The mechanics of polymethylmethacrylate augmentation. Clin Orthop Relat Res. 2006;443:124–130.
Kayanja MM, Schlenk R, Togawa D, Ferrara L, Lieberman I. The biomechanics of 1, 2, and 3 levels of vertebral augmentation with polymethylmethacrylate in multilevel spinal segments. Spine. 2006;31:769–774.
Pateder DB, Khanna AJ, Lieberman IH. Vertebroplasty and kyphoplasty for the management of osteoporotic vertebral compression fractures. Orthop Clin North Am. 2007;38: 409–418.
Barr JD, Barr MS, Lemley TJ, McCann RM. Percutaneous vertebroplasty for pain relief and spinal stabilization. Spine. 2000;25:923–928.
Keller TS, Kosmopoulos V, Lieberman IH. Vertebroplasty and kyphoplasty affect vertebral motion segment stiffness and stress distributions: a microstructural finite-element study. Spine. 2005;30:1258–1265.
Cortet B, Cotten A, Boutry N, et al. Percutaneous vertebroplasty in patients with osteolytic metastases or multiple myeloma. Rev Rhum Engl Ed. 1997;64:177–183.
Cotten A, Boutry N, Cortet B, et al. Percutaneous vertebroplasty: state of the art. Radiographics. 1998;18:311–320.
Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, Graves S, Staples MP, Murphy B. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009;361:557–568.
Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, Edwards R, Gray LA, Stout L, Owen S, Hollingworth W, Ghdoke B, Annesley-Williams DJ, Ralston SH, Jarvik JG. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009;361:569–579.
Wardlaw D, Cummings SR, Van Meirhaeghe J, et al. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet. 2009;373:1016–1024.
Vrionis FD, Hamm A, Stanton N, Sullivan M, Obadia M, Miguel RV. Kyphoplasty for tumor-associated spinal fractures. Tech Reg Anesth Pain Manag. 2005;9:35–39.
Khanna AJ, Reinhardt MK, Togawa D, Lieberman IH. Functional outcomes of kyphoplasty for the treatment of osteoporotic and osteolytic vertebral compression fractures. Osteoporos Int. 2006;17:817–826.
Shedid D, Togawa D, Lieberman IH. Kyphoplasty: vertebral augmentation for compression fractures. Clin Geriatr Med. 2006;22:535–544.
Harrop JS, Prpa B, Reinhardt MK, Lieberman I. Primary and secondary osteoporosis’ incidence of subsequent vertebral compression fractures after kyphoplasty. Spine. 2004;29:2120–2125.
Lieberman IH, Dudeney S, Reinhardt MK, Bell G. Initial outcome and efficacy of “kyphoplasty” in the treatment of painful osteoporotic vertebral compression fractures. Spine. 2001;26:1631–1638.
Pflugmacher R, Agarwal A, Kandziora F, K-Klostermann C. Balloon kyphoplasty combined with posterior instrumentation for the treatment of burst fractures of the spine – 1-year results. J Orthop Trauma. 2009;23:126–131.
Phillips FM, Wetzel FT, Lieberman I, Campbell-Hupp M. An in vivo comparison of the potential for extravertebral cement leak after vertebroplasty and kyphoplasty. Spine. 2002;27:2173–2179.
Pflugmacher R, Kandziora F, Schoeder RJ, Melcher I, Haas NP, Klostermann CK. Percutaneous balloon kyphoplasty in the treatment of pathological vertebral body fracture and deformity in multiple myeloma: a one-year follow-up. Acta Radiol. 2006;47:369–376.
Köse KC, Cebesoy O, Akan B, Altinel L, Dinçer D, Yazar T. Functional results of vertebral augmentation techniques in pathological vertebral fractures of myelomatous patients. J Natl Med Assoc. 2006;98:1654–1658.
Lane JM, Hong R, Koob J, et al. Kyphoplasty enhances function and structural alignment in multiple myeloma. Clin Orthop Relat Res. 2004;426:49–53.
Eck JC, Nachtigall D, Humphreys SC, Hodges SD. Comparison of vertebroplasty and balloon kyphoplasty for treatment of vertebral compression fractures: a meta-analysis of the literature. Spine J. 2008;8:488–497.
Khanna AJ, Neubauer P, Togawa D, Kay Reinhardt M, Lieberman IH. Kyphoplasty and vertebroplasty for the treatment of spinal metastases. Support Cancer Ther. 2005;3:21–25.
Lieberman I, Goins M, An H, Phillips F. Summary statement: kyphoplasty and nucleus pulposus prosthesis. Spine J. 2005;5(6 Suppl):325S.
Lieberman IH, Togawa D, Kayanja MM. Vertebroplasty and kyphoplasty: filler materials. Spin J. 2005;5(6 Suppl):305S–316S.
Bostrom MP, Lane JM.. Future directions. Augmentation of osteoporotic vertebral bodies. Spine. 1997;22(24 Suppl):38S–42S.
Togawa D, Bauer TW, Lieberman IH, Takikawa S. Histologic evaluation of human vertebral bodies after vertebral augmentation with polymethyl methylacrylate. Spine. 2003;28:1521–1527.
Togawa D, Lieberman IH, Bauer TW, Reinhardt MK, Kayanja MM. Histological evaluation of biopsies obtained from vertebral compression fractures: unsuspected myeloma and osteomalacia. Spine. 2005;30:781–786.
Togawa D, Kovacic JJ, Bauer TW, Reinhardt MK, Brodke DS, Lieberman IH. Radiographic and histologic findings of vertebral augmentation using polymethylacrylate in the primate spine: percutaneous vertebroplasty versus kyphoplasty. Spine. 2006;31:E4–E10.
Mroz TE, Yamashita T, Davros WJ, Lieberman IH. Radiation exposure to the surgeon and the patient during kyphoplasty. J Spinal Disord Tech. 2008;21:96–100.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hussein, M.A. (2010). Surgical Management of Bone Disease. In: Roodman, G. (eds) Myeloma Bone Disease. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-60761-554-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-60761-554-5_5
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-553-8
Online ISBN: 978-1-60761-554-5
eBook Packages: MedicineMedicine (R0)